Financhill
Buy
58

CCAP Quote, Financials, Valuation and Earnings

Last price:
$17.78
Seasonality move :
13.89%
Day range:
$17.71 - $17.96
52-week range:
$16.81 - $20.19
Dividend yield:
10.91%
P/E ratio:
8.93x
P/S ratio:
7.89x
P/B ratio:
0.89x
Volume:
132K
Avg. volume:
163.6K
1-year change:
0.74%
Market cap:
$659M
Revenue:
$83.5M
EPS (TTM):
$1.99

Analysts' Opinion

  • Consensus Rating
    Crescent Capital BDC has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 1 Hold rating, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $19.67, Crescent Capital BDC has an estimated upside of 10.61% from its current price of $17.78.
  • Price Target Downside
    According to analysts, the lowest downside price target is $18.00 representing 100% downside risk from its current price of $17.78.

Fair Value

  • According to the consensus of 4 analysts, Crescent Capital BDC has 10.61% upside to fair value with a price target of $19.67 per share.

CCAP vs. S&P 500

  • Over the past 5 trading days, Crescent Capital BDC has underperformed the S&P 500 by -0.63% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Crescent Capital BDC does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Crescent Capital BDC revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Crescent Capital BDC reported revenues of $12.4M.

Earnings Growth

  • Crescent Capital BDC earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Crescent Capital BDC reported earnings per share of $0.27.
Enterprise value:
1.5B
EV / Invested capital:
0.94x
Price / LTM sales:
7.89x
EV / EBIT:
11.41x
EV / Revenue:
18.26x
PEG ratio (5yr expected):
0.11x
EV / Free cash flow:
25.88x
Price / Operating cash flow:
11.19x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
4.48%
Net Income Margin (TTM):
88.2%
Return On Equity:
9.86%
Return On Invested Capital:
4.59%
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Income Statement
Revenue $23.2M $92.5M $83.5M $33M $12.4M
Gross Profit -- -- -- -- --
Operating Income -- -- -- -- --
EBITDA -- -- -- -- --
Diluted EPS $0.49 $2.30 $1.99 $0.84 $0.27
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Balance Sheet
Current Assets $6M $33.8M $24.5M $27.2M $27.1M
Total Assets $1.1B $1.3B $1.3B $1.6B $1.7B
Current Liabilities $17.4M $29M $29M $35.9M $35.3M
Total Liabilities $494.2M $665.5M $690.3M $884.8M $915.6M
Total Equity $560M $652.3M $612.5M $742.6M $740.6M
Total Debt $471.9M $631M $654.5M $844.8M $875.8M
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Cash Flow Statement
Cash Flow Operations $28M $92.3M $58.9M $34.6M -$2.9M
Cash From Investing -- -- -- -- --
Cash From Financing -$34.4M -$85M -$43.5M -$33M $5M
Free Cash Flow $28M $92.3M $58.9M $34.6M -$2.9M
CCAP
Sector
Market Cap
$659M
$616.2M
Price % of 52-Week High
88.06%
85.86%
Dividend Yield
10.91%
1.99%
Shareholder Yield
--
3.77%
1-Year Price Total Return
0.74%
8.45%
Beta (5-Year)
0.824
0.714
Dividend yield:
10.91%
Annualized payout:
$2.04
Payout ratio:
102.15%
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $17.60
200-day SMA
Sell
Level $18.73
Bollinger Bands (100)
Sell
Level 18.05 - 19.73
Chaikin Money Flow
Sell
Level -4.3M
20-day SMA
Buy
Level $17.62
Relative Strength Index (RSI14)
Sell
Level 46.49
ADX Line
Sell
Level 27.48
Williams %R
Sell
Level -15.6522
50-day SMA
Sell
Level $18.70
MACD (12, 26)
Sell
Level -0.33
25-day Aroon Oscillator
Sell
Level -56
On Balance Volume
Neutral
Level 3.8M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (0.5929)
Sell
CA Score (Annual)
Level (-0.3007)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (0.701)
--
Piotroski F Score (Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (4)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies.

Stock Forecast FAQ

In the current month, CCAP has received 3 Buy ratings 1 Hold ratings, and 0 Sell ratings. The CCAP average analyst price target in the past 3 months is $19.67.

  • Where Will Crescent Capital BDC Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Crescent Capital BDC share price will rise to $19.67 per share over the next 12 months.

  • What Do Analysts Say About Crescent Capital BDC?

    Analysts are divided on their view about Crescent Capital BDC share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Crescent Capital BDC is a Sell and believe this share price will drop from its current level to $18.00.

  • What Is Crescent Capital BDC's Price Target?

    The price target for Crescent Capital BDC over the next 1-year time period is forecast to be $19.67 according to 4 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.

  • Is CCAP A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Crescent Capital BDC is a Buy. 3 of 4 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of CCAP?

    You can purchase shares of Crescent Capital BDC via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Crescent Capital BDC shares.

  • What Is The Crescent Capital BDC Share Price Today?

    Crescent Capital BDC was last trading at $17.78 per share. This represents the most recent stock quote for Crescent Capital BDC. Yesterday, Crescent Capital BDC closed at $17.78 per share.

  • How To Buy Crescent Capital BDC Stock Online?

    In order to purchase Crescent Capital BDC stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Rivian a Good Stock a Buy?
Is Rivian a Good Stock a Buy?

Rivian Automotive (RIVN) had an initial IPO of close to…

Will Chevron Acquire Hess?
Will Chevron Acquire Hess?

Long-time Buffett favorite in the energy sector Chevron (NYSE:CVX) is…

Why Did Progressive Stock Go Down?
Why Did Progressive Stock Go Down?

Shares of insurance giant Progressive (NYSE:PGR) have fallen considerably over…

Stock Ideas

Buy
58
Is AAPL Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 37x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Sell
47
RGC alert for Mar 26

Regencell Bioscience Holdings [RGC] is up 4.9% over the past day.

Sell
39
W alert for Mar 26

Wayfair [W] is up 2.01% over the past day.

Sell
46
TSLA alert for Mar 26

Tesla [TSLA] is up 3.5% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock